Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01442896 · ClinicalTrials.gov registry record
STudy to Assess Rapid Disease Progression by Clinical and Genetic Factors In Glaucoma patientS That Are High Risk
A clinical trial, sponsored by University of California, San Diego.
- Completed
- Registry status
- 133
- Enrollment target
NCT01442896 is a clinical trial that has completed, run by University of California, San Diego. The registered enrollment target is 133 participants.
The verdict
NCT01442896 has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- 133 participants
- Enrollment target
Study Summary
The purpose of this study is to perform exploratory analyses to evaluate rates of functional and structural change in glaucoma, to identify predictors of rapid progression in patients with glaucoma and to identify possible genetic factors and biomarkers associated with the disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 133 participants |
| Start Date | 2011-09-01 |
| Est. Completion | 2015-12-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01442896
The ClinicalTrials.gov registry entry for NCT01442896 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 133 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01442896 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01442896 about?
NCT01442896 is a clinical study titled "STudy to Assess Rapid Disease Progression by Clinical and Genetic Factors In Glaucoma patientS That Are High Risk". The purpose of this study is to perform exploratory analyses to evaluate rates of functional and structural change in glaucoma, to identify predictors of rapid progression in patients with glaucoma and to identify possible genetic factors and biomarkers associated with the disease.
What is the current status of trial NCT01442896?
This trial is currently completed. The enrollment target is 133 participants. The study started on 2011-09-01. Estimated completion is 2015-12-18.
Who is sponsoring clinical trial NCT01442896?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.